T1000	Speculation 8379 8389	suggestive
E1000	Speculation:T1000 Scope:T1001
T1001	Span 8379 8442	suggestive of signals which are not equivalent in all parts [51
T1002	Speculation 5382 5388	seemed
E1001	Speculation:T1002 Scope:T1003
T1003	Span 5382 5410	seemed to be increased by GP
T1004	Negation 5930 5940	instead of
E1002	Negation:T1004 Scope:T1005
T1005	Span 5930 6036	instead of the conserved C in the TNFalpha motif, see Table 1), probably leading to differences in binding
T1006	Speculation 5994 6002	probably
E1003	Speculation:T1006 Scope:T1007
T1007	Span 5994 6043	probably leading to differences in binding [41,42
T1008	Negation 6201 6203	no
E1004	Negation:T1008 Scope:T1009
T1009	Span 6201 6214	no inhibition
T1010	Negation 4886 4896	instead of
E1005	Negation:T1010 Scope:T1011
T1011	Span 4886 4946	instead of the TNFalpha, IL-1beta, IL-6 or IFNgamma promoter
T1012	Speculation 4713 4716	may
E1006	Speculation:T1012 Scope:T1013
T1013	Span 4701 4909	this change may be caused by GP-mediated modulations of the TSST-1 induced binding of NFkappaB, NFIL-6 and NFAT to known and up to now unknown sites within the IL-8 and IL-1RA promoter instead of the TNFalpha
T1014	Speculation 4836 4843	unknown
E1007	Speculation:T1014 Scope:T1015
T1015	Span 4836 4946	unknown sites within the IL-8 and IL-1RA promoter instead of the TNFalpha, IL-1beta, IL-6 or IFNgamma promoter
T1016	Negation 5172 5175	not
E1008	Negation:T1016 Scope:T1017
T1017	Span 5172 5192	not shown in detail)
T1018	Negation 6411 6416	could
E1009	Negation:T1018 Scope:T1019
T1019	Span 6405 6437	which could not be altered by GP
T1020	Speculation 6411 6420	could not
E1010	Speculation:T1020 Scope:T1021
T1021	Span 6405 6437	which could not be altered by GP
T1022	Negation 8411 8414	not
E1011	Negation:T1022 Scope:T1023
T1023	Span 8411 8443	not equivalent in all parts [51]
T1024	Speculation 8160 8163	may
E1012	Speculation:T1024 Scope:T1025
T1025	Span 8150 8442	This idea may be supported by another study showing that despite the use of similar PRR, LPS and peptidoglycan activated the IL-1RA gene through different mechanisms/DNA-binding proteins and acted synergistically in combination, suggestive of signals which are not equivalent in all parts [51
T1026	Negation 503 510	absence
E1013	Negation:T1026 Scope:T1027
T1027	Span 503 623	absence of other stimuli, beta-1-->3-D-glucans induced binding of NFkappaB-, NFIL-6- and NFAT-mers to cytokine promoters
T1028	Speculation 57 64	suggest
E1014	Speculation:T1028 Scope:T1029
T1029	Span 57 203	suggest that a beta-1-->3-D-glucan like GP mediates its protective mechanisms, in part, via a rapid shift from NFkappaB- to PI3K-signaling [22,37]
T1030	Speculation 708 717	speculate
E1015	Speculation:T1030 Scope:T1031
T1031	Span 708 825	speculate that there is activation of several different NFAT isoforms, probably derived from alternative splicing [38
T1032	Speculation 479 494	indicating that
E1016	Speculation:T1032 Scope:T1033
T1033	Span 479 527	indicating that, in the absence of other stimuli
T1034	Negation 1476 1487	rather than
E1017	Negation:T1034 Scope:T1035
T1035	Span 1476 1575	rather than via p65/50 heterodimers, which might be the case for the GP-mediated IL-8 transcription
T1036	Speculation 779 787	probably
E1018	Speculation:T1036 Scope:T1037
T1037	Span 779 825	probably derived from alternative splicing [38
T1038	Speculation 1742 1747	seems
E1019	Speculation:T1038 Scope:T1039
T1039	Span 1742 1761	seems also possible
T1040	Speculation 1519 1524	might
E1020	Speculation:T1040 Scope:T1041
T1041	Span 1519 1575	might be the case for the GP-mediated IL-8 transcription
T1042	Negation 2139 2142	not
E1021	Negation:T1042 Scope:T1043
T1043	Span 2139 2158	not induce IL-1beta
T1044	Speculation 1753 1761	possible
E1022	Speculation:T1044 Scope:T1045
T1045	Span 1753 1761	possible
T1046	Speculation 8031 8034	may
E1023	Speculation:T1046 Scope:T1047
T1047	Span 8031 8148	may offer an explanation for a difference in signaling between GP (PI3K) and LPS (mitogen-activated kinase signaling)
T1048	Negation 7842 7845	not
E1024	Negation:T1048 Scope:T1049
T1049	Span 7842 7870	not IL-1beta production [48]
T1050	Speculation 2520 2534	indicated that
E1025	Speculation:T1050 Scope:T1051
T1051	Span 2520 2794	indicated that GP leads to production of IL-1RA primarily via induction of NFATP2/3 and NFIL-6 DNA binding, which might be due to differences in the binding motif or the composition of the activated transcription factors (NFAT) between the IFNgamma, IL-6 and IL-1RA promoter
T1052	Speculation 2192 2202	suggesting
E1026	Speculation:T1052 Scope:T1053
T1053	Span 2192 2249	suggesting an immediate anti-inflammatory potential of GP
T1054	Speculation 2983 2988	might
E1027	Speculation:T1054 Scope:T1055
T1055	Span 2983 3081	might suggest that these steps are linked to each other and necessary for induction of IL-1RA (Fig
T1056	Speculation 2634 2639	might
E1028	Speculation:T1056 Scope:T1057
T1057	Span 2634 2794	might be due to differences in the binding motif or the composition of the activated transcription factors (NFAT) between the IFNgamma, IL-6 and IL-1RA promoter
T1058	Negation 3339 3342	not
E1029	Negation:T1058 Scope:T1059
T1059	Span 3333 3349	(data not shown)
T1060	Speculation 2989 2996	suggest
E1030	Speculation:T1060 Scope:T1061
T1061	Span 2989 3081	suggest that these steps are linked to each other and necessary for induction of IL-1RA (Fig
T1062	Speculation 3455 3461	likely
E1031	Speculation:T1062 Scope:T1063
T1063	Span 3455 3536	likely due to differences in recognition and signaling between LPS, TSST-1 and GP
T1064	Speculation 3225 3231	seemed
E1032	Speculation:T1064 Scope:T1065
T1065	Span 3225 3304	seemed to confirm that monocytes and neutrophils were able to produce IL-8 just
T1066	Speculation 4176 4184	possible
E1033	Speculation:T1066 Scope:T1067
T1067	Span 4176 4201	possible microbial attack
T1068	Speculation 4096 4099	may
E1034	Speculation:T1068 Scope:T1069
T1069	Span 4096 4201	may well fit to a benign PAMP response, mounting defensive mechanisms against a possible microbial attack
T1070	Speculation 6719 6722	may
E1035	Speculation:T1070 Scope:T1071
T1071	Span 6719 6800	may explain the synergistic up-regulation of the TSST-1-induced IL-1RA production
T1072	Speculation 6465 6468	may
E1036	Speculation:T1072 Scope:T1073
T1073	Span 6465 6556	may therefore represent at least a part of the previoulsy described inhibitory element [30]
T1074	Speculation 7687 7690	may
E1037	Speculation:T1074 Scope:T1075
T1075	Span 7687 7727	may be sustained by GP treatment [22,37]
T1076	Speculation 7499 7502	may
E1038	Speculation:T1076 Scope:T1077
T1077	Span 7404 7604	The weaker modulating effects of GP on the LPS-induced immune response observed in this study, may be attributed to delicately balanced differences in signaling pathways between LPS and TSST-1 [43-45]
T1078	Negation 7381 7384	not
E1039	Negation:T1078 Scope:T1079
T1079	Span 7375 7401	(data not shown in detail)
T1080	Negation 7201 7204	not
E1040	Negation:T1080 Scope:T1081
T1081	Span 7201 7282	not unreasonable to assume that IL-1beta bioactivity is inactivated in our system
T1082	Speculation 7048 7053	might
E1041	Speculation:T1082 Scope:T1083
T1083	Span 7048 7099	might control the biological effects of IL-1 [46,47
T1084	Speculation 6805 6810	think
E1042	Speculation:T1084 Scope:T1085
T1085	Span 6805 6947	think that this GP-modulated activation of transcription was reflected by the decrease of the IL-1beta/IL-1RA ratio following GP + TSST-1 (Fig
